Well Told Grants

Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-IP-24-081: Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China

Closed Closed March 8, 2024 Opportunity RFA-IP-24-081

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.

Centers for Disease Control and Prevention - ERA offered grants of up to $350,000 (at least $150,000) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expected to make one award worth $4.3 million in total. Applications closed on March 8, 2024.

From the official notice on Grants.gov, last changed December 21, 2023. Checked November 7, 2026.

Other notices with this title

Centers for Disease Control and Prevention - ERA has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-IP-23-001November 15, 2022Closed February 9, 2023Closed

Key dates

PostedDecember 21, 2023
DeadlineMarch 8, 2024
Archived by Grants.govApril 7, 2024

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes and businesses.

All 14 applicant types the notice lists

Foreign Organization: a Foreign Organization is a public or private organization, whether non-profit or for-profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance.

More grants for nonprofits, colleges and universities, state and local governments, tribes, businesses.

Is this a realistic fit?

What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to support enhanced surveillance and applied research for influenza virus or other respiratory infections in humans and animals in China. This support aims to better define the global risk and to build the evidence for prevention and control of novel and seasonal avian and non-avian seasonal influenza viruses and other respiratory diseases in China. The scope of research performed will include, but will not be limited to, activities such as estimating the burden and cost of illness for groups at high risk for severe disease; monitoring vaccine uptake and efficacy; promoting vaccine programs for groups at high risk for severe influenza complications; and conducting surveillance for detection and control of novel and seasonal influenza viruses and other respiratory pathogens. Research activities for the prevention and control of novel and seasonal influenza viruses and other respiratory pathogens and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission within China and potentially to other countries, including the United States. Continued monitoring, detection, and reporting of these influenza viruses and other respiratory pathogens in China will advance global health efforts. These activities will assist to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. This NOFO provides an opportunity to conduct research in these important areas.

Category: Health.

Who has won Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases grants before

From fiscal 2021 to 2025, Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases (93.083) awarded $58.2 million across 30 grant awards, an average of $1.9 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Council of Medical SpeciaIllinois1$40.4 million
Post-Acute and Long-Term Care Medical Association, Inc.Maryland1$7.1 million
National Health Laboratory Service1$3.1 million
All India Institute of Medical Sciences1$1.0 million
American Cancer Society, IncGeorgia2$900,000

Top states: Illinois ($40.9 million), Maryland ($7.2 million), California ($1.3 million), Washington ($1.1 million), Georgia ($900,000).

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-IP-24-081 still open?

No. It closed on March 8, 2024. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

Who can apply for Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China?

Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China?

Closed March 8, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $350,000 each. About $4.3 million in total for one award.

Who has won Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases grants before?

The largest recipients over five fiscal years were Council of Medical Specia, Post-Acute and Long-Term Care Medical Association, Inc., National Health Laboratory Service. The program made 30 awards worth $58.2 million in that time.

Similar open grants